SEC Tracker
Get the app

BioXcel Therapeutics BTAIQ

Oaktree Fund Advisors updates its stake in BioXcel Therapeutics to 0.83%

Form
Schedule 13G/A
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

Ownership stake disclosure (amended)

View on EDGAR

Open in the app

Get an email when BioXcel Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Phio Pharmaceuticals PHIO public float $11M, Jun 30, 2025
  2. Palisade Bio PALI public float $11M, Jun 30, 2025
  3. Citius Pharmaceuticals CTXR public float $11M, Mar 31, 2025, over 18 months old
  4. Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
  5. Cocrystal Pharma COCP public float $12M, Jun 30, 2025